Cell Therapy is Associated with Reduction of Functional Mitral Regurgitation in Cardiomyopathy Patients with High End-Diastolic Volumes

In nonischemic cardiomyopathy (NICM), CD34+ cell transplantation was shown to improve left ventricular dimensions and function. We sought to investigate the effects of such therapy on functional mitral regurgitation (FMR) in this patient cohort.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 328 Source Type: research